Eli Lilly Reports Strong Q1 2026 Earnings Raises FullYear Guidance on Mounjaro Momentum and GLP1 Demand SP 500 Reaches Record High Amid Hopes for Iran Peace GitHubs AI Coding Ambitions Face Outage Setbacks as Competition Intensifies ADP Reports Private Payrolls Rise 109000 in April Exceeding Expectations Sirma Group Holding AD Reports Strong Profitability Growth in Q1 2026 Smallcase Managers Forecast Nifty 50 Could Reach 2800030000 by FY27 Amid 9 YTD Decline AWK Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain NACCO Industries Q1 2026 Earnings EPS Beats with 117 Amid Limited Visibility ConnectOne Bancorp Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Reaction Block Inc XYZ Q1 2026 Earnings Strong EPS Beat of 2443 Surprises Markets Shares Dip Slightly Polestar Q4 2024 Earnings Massive EPS Miss Highlights Mounting Losses Stock Slides LEDS Q1 2026 Earnings Loss Reported as Stock Surges 1268 Amid Market Optimism Fuel Tech Inc FTEK Pushes Higher as Shares Approach the 160 Resistance Zone DFP Holds Steady Near 20 as Preferred Income Fund Displays Resilience Quartzsea Acquisition Rights QSEAR Holds Steady at 023 as Trading Remains Rangebound Leishen Energy Holding LSE Consolidates Near Resistance After Modest Gain PNC Financial Services Holds Steady Above 220 as Bulls Eye Key Resistance Prediction Markets Face Growing State and Federal Regulatory Clash 16 States in Legal Proceedings One Bans Platforms GOOG Q1 2026 Earnings EPS Misses Estimates Amid Continued AI Investment Compass Inc COMP Edges Higher as Real Estate Tech Sector Shows Resilience ESCO Technologies Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates Valaris Limited VAL Q1 2026 Earnings EPS Misses Wide Stock Holds Steady EC Q4 2025 Earnings EPS Misses Estimates Amid Mixed Operational Performance CRGY Q1 2026 Earnings Strong EPS Beat Amid Energy Market Volatility JBLU Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Persist ELTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline